Biocon Biologics collaborates with RSSDI for diabetes management

Biocon Biologics with Research Society for the Study of Diabetes in India (RSSDI) will identify and train around 400 physicians in different districts across the country to address the issue of Type 1 diabetes in children. Biocon Biologics will enable these healthcare professional (HCPs) with a free supply of its insulins portfolio to help over 1,000 children with Type 1 diabetes, from the marginalised communities, who otherwise cannot afford this therapy.

As a part of this initiative, RSSDI teams will develop the training material, as well as, will train these physicians, to create awareness on effective diabetes management in Type 1 patients, among their peers, and the community at large in their respective districts. Biocon Biologics will provide, educational and other diabetes awareness materials for these training programmes as well as will facilitate organising of these events.